When was Sample6 founded?

Sample6 was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Where is Sample6 located?

Sample6 is headquartered in Boston, United States.

How many employees does Sample6 have?

As of Aug 31, 2026, the latest employee count at Sample6 is 1.

Is Sample6 a funded company?

Sample6 is a funded company, having raised a total of $32M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 22, 2010.

When was the latest funding round of Sample6?

Sample6's latest funding was a $***** Grant (prize money) round on Jul 12, 2017, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.29B in funding in 2026 to date.

Where does Sample6 rank among its competitors?

Sample6 ranks 133rd amongst 2070 active competitors, of which 459 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was One Biosciences, which secured $3.76M in Sep, 2026.

Who are the top competitors of Sample6?

Sample6's top competitors include Antheia, Transcenta and Akeso. Among them, One Biosciences secured the most recent funding round in September, 2026.

Sample6 - 2026 Company Profile, Team, Funding & Competitors

Company Details

Food safety laboratories and consulting group providing testing and training. They offer comprehensive laboratory testing services, including food microbiology, analytical chemistry, allergen testing, authenticity testing, bioengineered food analysis, and more. Their expert consultation services cover crisis management, environmental monitoring, and food safety plan development. They provide training programs through their academy, ensuring food safety and sanitation knowledge from C-Suite executives to line workers. They are dedicated to facilitating the production of wholesome foods through expedited laboratory testing services and expert consultation, supporting regulatory compliance and ensuring food safety across the industry. They offer analytical testing and food safety consulting services.

Key Metrics

Founded Year

2009

Location

Boston, United States

Stage

Acquired

Total Funding

$32M in 10 rounds

Latest Funding Round

Grant (prize money), Jul 12, 2017, $*****

Investors

Canaan & 10 more

Ranked

133^rd among 2070 active competitors

Employee Count

1 as on Aug 31, 2026

Similar Companies

Antheia & 2754 more

Exit Details

Acquired by IEH Laboratories and Consulting Group (Nov 28, 2017)

View Sample6's full profile

Sample6 got acquired by IEH Laboratories and Consulting Group on Nov 28, 2017.

Click here to take a look at Sample6's acquisition in detail

Sample6 has raised a total funding of $32M over 10 rounds. Its first funding round was on Oct 22, 2010. Its latest funding round was a Grant (prize money) round on Jul 12, 2017 for $*****. 1 investor participated in its latest round. Sample6 has 11 institutional investors.

Here is the list of recent funding rounds of Sample6:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 12, 2017	6392541	Grant (prize money)	2559305	8479826	5680531	7771300
Apr 01, 2017	8190691	Grant (prize money)	9762009	1321867	4044262	HHS
Aug 22, 2016	1924537	Series C	1607640	9694951	3273660	Acre Venture Partners & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Sample6's funding rounds and investors

The founders of Sample6 are Tim Lu and Michael Koeris.

Here are the details of Sample6's key team members:

Tim Lu: Co-Founder of Sample6 and founder of 1 other company.
Contact Info: 2 email addresses
Michael Koeris: Former Co-Founder of Sample6.

View details of Sample6's Founder profiles and Board Members

Sample6's employee count trend

Sample6 has 1 employees as of Aug 26. Here is Sample6's employee count trend over the years:

Uncover Sample6's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sample6 include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Sample6, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
2nd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
3rd	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
4th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
5th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
6th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
7th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
8th	LifeMine Therapeutics 2016, Watertown (United States), Series E	Developer of novel drugs from fungi via genome mining and recombinant overexpression	$563M	Fidelity Investments, 6 Dimensions Capital ... & 17 others	63/100
9th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 7 others	63/100
10th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$364M	Maverick Ventures, SoftBank Vision Fund & 16 others	62/100
133rd	Sample6 2009, Boston (United States), Acquired	Food safety laboratories and consulting group providing testing and training	$32M	Canaan, Valley Oak Investments & 9 others	48/100